1st Biotherapeutics Patents – Key Insights & Stats

1st Biotherapeutics has a total of 74 patents globally, out of which 11 have been granted. Of these 74 patents, more than 83% patents are active. The United States of America is where 1st Biotherapeutics has filed the maximum number of patents, followed by Europe. Parallelly, United States of America seems to be the main focused R&D centre and also Korea (South) is the origin country of 1st Biotherapeutics.

1st Biotherapeutics was founded in 2016. 1st Biotherapeutics is dedicated to developing breakthrough therapies with the goal of providing patients with revolutionary medicines.

Do read about some of the most popular patents of 1st Biotherapeutics which have been covered by us in this article and also you can find 1st Biotherapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over 1st Biotherapeutics patent portfolio.

How many patents do the Founder and CEO of 1st Biotherapeutics have?

The Founder and CEO Jamie Jae Eun Kim have 0 patents.

How many patents does 1st Biotherapeutics have?

1st Biotherapeutics has a total of 74 patents globally. These patents belong to 10 unique patent families. Out of 74 patents, 62 patents are active.

How Many Patents did 1st Biotherapeutics File Every Year?

1st Biotherapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or Grant1st Biotherapeutics Applications Filed1st Biotherapeutics Patents Granted
202335
202212
2021282
2020291
201911
201812

How many 1st Biotherapeutics patents are Alive/Dead?

Worldwide Patents

1st Biotherapeutics Patent Portfolio

How Many Patents did 1st Biotherapeutics File in Different Countries?

1st Biotherapeutics Worldwide Patent Filing

Countries in which 1st Biotherapeutics Filed Patents

CountryPatent
United States Of America11
Europe9
Korea (South)8
China8
Japan6
Australia4
Canada4
Mexico3
Israel3
Taiwan2
Russia2
Hong Kong (S.A.R.)2
Germany1
Austria1

Where are Research Centers of 1st Biotherapeutics Patents Located?

R&D Centres of 1st Biotherapeutics

What Percentage of 1st Biotherapeutics US Patent Applications Were Granted?

1st Biotherapeutics (Excluding its subsidiaries) has filed 11 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 4 have been granted leading to a grant rate of 100%.

Below are the key stats of 1st Biotherapeutics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for 1st Biotherapeutics?

Law FirmTotal ApplicationsSuccess Rate
Harness Dickey St Louis11100%

What are 1st Biotherapeutics key innovation segments?

What Technologies are Covered by 1st Biotherapeutics?

The chart below distributes patents filed by 1st Biotherapeuticsin different countries on the basis of the technology protected in patents. It also represents the markets where 1st Biotherapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has 1st Biotherapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by 1st Biotherapeutics?

Related Articles

Pavegen Patents – Insights & Stats (Updated 2024)

Pavegen has a total of 36 patents globally, out of which 26 have been granted. Of these 36 patents, more than 47% patents are active. United Kingdom is where Pavegen has filed the maximum number of patents, followed by Europe (EPO) and Austria. Parallelly, United Kingdom seems to be the

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.